Artificial Disc Designs To Converge In A Decade – Spine Surgeon Sasso
This article was originally published in The Gray Sheet
Executive Summary
Despite wide variations in the designs of lumbar and cervical artificial discs, device firms will eventually move toward more unified platforms for each as the market matures, Rick Sasso, MD, Indiana Spine Group, believes
You may also be interested in...
NuVasive Prepares Cervical Disc IDE Filing; Fusion Plate To Launch In July
NuVasive intends to file an IDE application for a minimally-invasive cervical total artificial disc replacement within the next two weeks
Zimmer Aims To Sway Hospitals On MIS Cost-Savings, Dismisses Charité
Zimmer plans to drive hospital adoption of its MIS 2-Incision hip and MIS Quad-Sparing knee procedures by touting their ability to spur hospital profits
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.